Latest Reported Offering
$50,001
Target Amount
$2,620,013
Maximum Amount
2027-04-30
Deadline
Security Details
Type: Preferred Stock
Price per share: $4.70
Price set by: Dividing pre-money valuation $90,000,000.00 (or $81,386,531.00 for investors in the first $449,998.50) by number of shares outstanding on fully diluted basis.
Shares offered: 11,765+
Offering Costs
Cash commission: 6.5%
of the offering amount upon a successful fundraise, and be entitled to reimbursement for out-of-pocket third party expenses it pays or incurs on behalf of the Issuer in connection with the offering.
Equity compensation: —
No
Filing history
Form C family — 9 filingsThe reported figures behind Koios Medical, Inc.
Form C prints a most-recent and a prior fiscal year side by side but never names them. The dashboard chains every filing into those years and plots them. EDGAR still has each Form C-AR; the dashboard lays every year they filed next to it.
- Reported financials chained into fiscal years — revenue, income, assets, cash — not one filing at a time
- A sparkline on each figure so the shape is visible before the numbers
- A revenue series dated to the filings that reported it
- The campaign as filed: target, ceiling, deadline, and the portal that ran it
- Follow it, and see it change on your watchlist
Part of the Alts plan — $40/mo at launch pricing ($100 list)
Company Information
Legal Status
Corporation
Jurisdiction
Delaware
Date of Incorporation
2011-04-06
Website
Latest Metrics
Employees12
Total Assets$753,413
Cash on Hand$168,058
Revenues$1,620,593
Net Income-$2,687,228
Crowdfunding Portals
The intermediary named in this company’s Form C filings. Investments in a Regulation Crowdfunding offering can only be made through them.